Приказ основних података о документу

dc.creatorPavlović, Bojana
dc.creatorCvijetić, Nataša
dc.creatorDragačević, Luka
dc.creatorIvković, Branka
dc.creatorVujić, Zorica
dc.creatorKuntić, Vesna
dc.date.accessioned2021-02-18T10:47:10Z
dc.date.available2021-02-18T10:47:10Z
dc.date.issued2016
dc.identifier.issn1060-3271
dc.identifier.urihttp://intor.torlakinstitut.com/handle/123456789/469
dc.description.abstractOne of the most commonly used surfactants in the production of split virus influenza vaccine is nonionic surfactant Triton X-100. After splitting of the virus is accomplished, Triton X-100 is removed from the vaccine by subsequent production steps. Because of toxicity of Triton X-100, which remains in the vaccine in residual amounts, a sufficiently sensitive method for its detection and quantification needs to be defined. Two methods for determination of Triton X-100 residuals were developed: the UV-spectrophotometry and HPLC methods. For both methods, preparation of vaccine samples and removal of proteins and virus particles were crucial: samples were treated with methanol (1:1) and then centrifuged at 25000 x g for 30 min. After such treatment, the majority of vaccine components that interfered in the UV region were removed, and diluted samples could be directly measured. The chromatographic system included C18 column, step methanol gradient, and detection at 225 nm with a single peak of Triton X-100 at 12.6 min. Both methods were validated and gave satisfactory results for accuracy, precision, specificity, linearity, and robustness. LOQ was slightly lower for the HPLC method. Hence, it was shown that both methods are suitable for analysis of residual amounts of Triton X-100, with the advantages of the UV method being its simplicity and availability in most laboratories.en
dc.publisherOxford Univ Press Inc, Cary
dc.relationinfo:eu-repo/grantAgreement/MESTD/Basic Research (BR or ON)/172041/RS//
dc.rightsrestrictedAccess
dc.sourceJournal of AOAC International
dc.titleDirect UV Spectrophotometry and HPLC Determination of Triton X-100 in Split Virus Influenza Vaccineen
dc.typearticle
dc.rights.licenseARR
dc.citation.epage400
dc.citation.issue2
dc.citation.other99(2): 396-400
dc.citation.rankM23
dc.citation.spage396
dc.citation.volume99
dc.identifier.doi10.5740/jaoacint.15-0201
dc.identifier.pmid26960682
dc.identifier.scopus2-s2.0-84964241009
dc.identifier.wos000374203700011
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу